Scott Bryson
Impact in
-
- Antibiotic Use and Resistance
- Pharmacology top 10%
- Antibiotics Pharmacokinetics and Efficacy
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Antibiotics Pharmacokinetics and Efficacy 4
- Pharmacogenetics and Drug Metabolism 2
- Co-authors
- B. Whiting (3 shared papers)Michael A. McGuigan (1 shared paper)Alison H. Thomson (1 shared paper)A. W. Kelman (1 shared paper)Melissa Givens (1 shared paper)Alexander B. Mullen (1 shared paper)Jake J. Thiessen (2 shared papers)Mark Greenberg (2 shared papers)
- Journals
- The Journal of Pediatrics (1 paper)Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (1 paper)Therapeutic Drug Monitoring (1 paper)Cancer Biology & Therapy (1 paper)British Journal of Clinical Pharmacology (1 paper)
- Partner nations
- United KingdomCanadaUnited States
In The Last Decade
Scott Bryson
18 papers receiving 382 citations
Peers
Comparison fields: 5 of 96
- Applied Microbiology and Biotechnology 34
- Pharmacology 131
- Geriatrics and Gerontology 23
- Pharmacology 49
- Emergency Medicine 33
Countries citing papers authored by Scott Bryson
This map shows the geographic impact of Scott Bryson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Bryson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Bryson more than expected).
Fields of papers citing papers by Scott Bryson
This network shows the impact of papers produced by Scott Bryson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Bryson. The network helps show where Scott Bryson may publish in the future.
Co-authors
The 25 scholars most cited alongside Scott Bryson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1983 | 125 | |
| 2 | 1988 | 49 | |
| 3 | 2013 | 41 | |
| 4 | 2011 | 25 | |
| 5 | 1988 | 23 | |
| 6 | Comparison of methanol exposure routes reported to Texas poison control centers. | 2008 | 20 |
| 7 | 1995 | 19 | |
| 8 | 2016 | 17 | |
| 9 | 1989 | 13 | |
| 10 | 1982 | 13 | |
| 11 | 1982 | 12 | |
| 12 | 1990 | 10 | |
| 13 | 1994 | 9 | |
| 14 | 1991 | 9 | |
| 15 | 2001 | 6 | |
| 16 | 2023 | 3 | |
| 17 | 2022 | 1 | |
| 18 | 1982 | 1 | |
| 19 | Arts traditionnels et histoire au Zaïre : cultures forestières et royaumes de la savane | 1981 | 0 |
About Scott Bryson
Scott Bryson is a scholar working on Pharmacology, Molecular Biology, Pediatrics, Perinatology and Child Health, Pulmonary and Respiratory Medicine and Oncology, having authored 19 papers that have together received 396 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (4 papers), Poisoning and overdose treatments (3 papers), Metabolism and Genetic Disorders (2 papers), Pharmacogenetics and Drug Metabolism (2 papers), Pharmaceutical studies and practices (2 papers), Drug Solubulity and Delivery Systems (1 paper), Colorectal Cancer Treatments and Studies (1 paper) and Analytical Methods in Pharmaceuticals (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (34 citations), Pharmacology (131 citations), Geriatrics and Gerontology (23 citations), Pharmacology (49 citations) and Emergency Medicine (33 citations). Scott Bryson has collaborated with scholars based in United Kingdom, Canada and United States. Frequent co-authors include B. Whiting, Michael A. McGuigan, Alison H. Thomson, A. W. Kelman, Melissa Givens, Alexander B. Mullen, Jake J. Thiessen, Mark Greenberg, Andrew W. Kelman and J. Anthony Brandon. Their work appears in journals such as The Journal of Pediatrics, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, Therapeutic Drug Monitoring, Cancer Biology & Therapy and British Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.